Not recruiting
Squamous cell carcinoma of head and neck
Not recruitingStudy of pucotenlimab with becotatug vedotin versus becotatug vedotin alone for patients with locally advanced head and neck squamous cell carcinoma
InvestigationalNo placebo
Study of pucotenlimab with becotatug vedotin versus becotatug vedotin alone for patients with locally advanced head and neck squamous cell carcinoma
InvestigationalNo placebo
- Disease:Squamous cell carcinoma of head and neck
- Substances:Pucotenlimab
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Pucotenlimab